The management of febrile neutropenia is a backbone of treating patients with hematologic malignancies and has evolved over the past decades. This article reviews my approach to the evaluation and treatment of febrile neutropenic patients. Key topics discussed include antibacterial and antifungal prophylaxis, the initial workup for fever, the choice of the empiric antibiotic regimen and its modifications, and criteria for discontinuation. For each of these questions, I review the literature and present my perspective.
CITATION STYLE
Nucci, M. (2021, March 1). How I treat febrile neutropenia. Mediterranean Journal of Hematology and Infectious Diseases. Universita Cattolica del Sacro Cuore. https://doi.org/10.4084/MJHID.2021.025
Mendeley helps you to discover research relevant for your work.